Our passion is focused
on the mobility of animals

Advancing joint care
for dogs and horses.

Enhancing the quality of life for animals is a goal we passionately share with the veterinary professionals, pet parents and horse owners we serve. It’s why our portfolio is focused on delivering solutions to help support joint health in unique and important ways.

With millions of doses administered1, we're proud that veterinarians and the clients they serve have relied on our products for over 30 years.

dog and horse by fence

Our FDA-Approved solutions

Adequan Logo First of its kind.
Still one of a kind.
LEARN MORE
Canine Logo The difference between feeling
better and getting better.®
LEARN MORE
BetaVet Logo The link between rapid onset and long acting relief of pain and inflammation2 LEARN MORE

Easy ordering for veterinary practices.

Our FDA-Approved prescription products are only available for use by or on the order of licensed veterinarians. Veterinarians can conveniently order our equine products in multiple ways, including by phone, fax or online. Our canine product is available through select veterinary distributors.

Learn more about ordering our products.

If you are a dog or horse owner interested in our products, please contact your prescribing veterinarian to discover if our products are right for your animal.

We’re here to help.

We are committed to providing veterinarians and pet owners the help you need when and where you need it. Please contact us for answers and information.

Adequan® i.m. Brand of Polysulfated Glycosaminoglycan (PSGAG)

INDICATIONS
Adequan® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
IMPORTANT SAFETY INFORMATION
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan. Studies have not been conducted to establish safety in breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For full prescribing information, click here.


BetaVet® (betamethasone sodium phosphate and betamethasone acetate injectable suspension)
For Intra-articular (I.A.) use in Horses.

INDICATIONS
BetaVet® is indicated for the control of pain and inflammation associated with osteoarthritis in horses.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS: BetaVet® is contraindicated in horses with hypersensitivity to betamethasone. Intra-articular injection of corticosteroids for local effect is contraindicated in the presence of septic arthritis. WARNINGS: Do not use in horses intended for human consumption. Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have resulted congenital anomalies. Before use of corticosteroids in pregnant animals, the possible benefits should be weighed against potential hazards. Human Warnings: Not for use in humans. Keep this and all medications out of the reach of children. PRECAUTIONS: Corticosteroids, including BetaVet®, administered intra-articularly are systemically absorbed. Do not use in horses with acute infections. Acute moderate to severe exacerbation of pain, further loss of joint motion, fever, or malaise within several days following intra-articular injection may indicate a septic process. Because of the anti-inflammatory action of corticosteroids, signs of infection in the treated joint may be masked. Due to the potential for exacerbation of clinical signs of laminitis, glucocorticoids should be used with caution in horses with a history of laminitis, or horses otherwise at a higher risk for laminitis. Use with caution in horses with chronic nephritis, equine pituitary pars intermedia dysfunction (PPID), and congestive heart failure. Concurrent use of other anti-inflammatory drugs should be approached with caution. Consider appropriate wash out times prior to administering additional NSAIDs or corticosteroids. ADVERSE REACTIONS: Adverse reactions reported during a field study of 239 horses of various breeds which had been administered either BetaVet® (n=119) or a saline control (n=120) at five percent (5%) and above were: acute joint effusion and/or local injection site swelling (within 2 days of injection), 15% BetaVet® and 13% saline control; increased lameness (within the first 5 days), 6.7% BetaVet® and 8.3% saline control; loose stool, 5.9% BetaVet®and 8.3% saline control; increased heat in joint, 2.5% BetaVet® and 5% saline control; and depression, 5.9% BetaVet® and 1.6% saline control. SHAKE WELL IMMEDIATELY BEFORE USE. For additional safety information, please see full prescribing information. CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.


Adequan® Canine Brand of Polysulfated Glycosaminoglycan (PSGAG)

INDICATIONS
Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
IMPORTANT SAFETY INFORMATION
Adequan® Canine should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Adverse reactions in clinical studies (transient pain at injection site, transient diarrhea, and abnormal bleeding) were mild and self-limiting. In post approval experience, death has been reported in some cases; vomiting, anorexia, depression/lethargy and diarrhea have also been reported. The safe use of PSGAG in breeding, pregnant or lactating dogs has not been evaluated. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information.
1. Data on file.
2. Trotter GW. Intra-articular corticosteroids. In: McIlwraith CW, Trotter GW, eds. Joint Disease in the Horse, Philadelphia, PA; W.B. Saunders, 1996; 237-256.

Let’s stay in touch.

Be the first to hear about important news and product information!
First, select the one that best describes you.
Then we’ll take you to our sign up page.

EQUINE VETERINARY
PROFESSIONAL
CANINE VETERINARY
PROFESSIONAL
HORSE OWNER DOG OWNER